Strata® 44421 (UDI 00763000027520)Recalls & reported problems
Medtronic Ps Medical, Inc. · KIT 44421 STRATA NSC LP OPEN LUMBAR · Class 2 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00763000027520), received between Mar 26, 2025 and Sep 11, 2026 — classified as 1 injury, 5 malfunctions.
The most frequently reported specific device problem is “Break” (4 reports).
1 other recall cover devices cleared under the same FDA submission (K123524); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Break4
- Fracture4
- Fluid/Blood Leak1
- Mechanics Altered1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Blurred Vision1
- Headache1
- Nausea1
- Seroma1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 11, 2026Mechanics Altered
Medtronic received information regarding an adjustable valve. It was reported that the patient was diagnosed with idiopathic intracranial hypertension after failure of conservative management. Following a detailed discussion of the available treatment options with the patient and their family, the decision was made to proceed with placement of a lumboperitoneal (LP) shunt. Prior to surgery, the valve was programmed to a setting of 1.5.The procedure was performed on (b)(6) 2025, and was uneventful. Following surgery, the patient experienced gradual and significant improvement in her symptoms. Approximately one month postoperatively, however, the patient reported recurrence of her symptoms, including headaches, nausea and blurred vision. Appropriate investigations were performed to assess the position of the shunt, which demonstrated that the shunt was appropriately positioned without evidence of malposition. The valve setting was subsequently checked and was found to have changed from the original setting of 1.5 to 1.0. The valve was reprogrammed to 1.5, following which the patient's symptoms again improved. Of note, during this period, the patient had not undergone MRI examination
Patient problems: Blurred Vision; Headache; Nausea
MAUDE report 50732520 ↗MalfunctionJan 29, 2026Break; Fracture
MEDTRONIC RECEIVED INFORMATION REGARDING A SHUNT. IT WAS REPORTED THAT ON (B)(6) 2025, THE DOCTOR DISCOVERED CATHETER DAMAGE DURING A LUMBOSACRAL PERITONEAL SHUNT PROCEDURE USING THE REPORTED DEVICE IN THE OPERATING ROOM. THE PROCEDURE WAS COMPLETED BY REPLACING IT WITH A PRODUCT OF THE SAME MODEL. THE PATIENT'S STATUS AT THE TIME OF THE REPORT WAS ALIVE-NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24208898 ↗MalfunctionOct 28, 2025Break; Fracture; Break; Fracture
MEDTRONIC RECEIVED INFORMATION REGARDING A VALVE/SHUNT. IT WAS REPORTED THAT ON THE OPERATING TABLE, AFTER OPENING THE PACKAGE, THE SURGEON ROUTINELY CHECKED THE VALVE AND CATHETER PATENCY AND FOUND THAT THE LUMBAR SEGMENT TUBE WAS DAMAGED. THE DEVICE WAS REPLACED WITH A NEW ONE. NO PATIENT INVOLVEMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23402985 ↗MalfunctionSep 11, 2025Break; Fracture; Break; Fracture
MEDTRONIC RECEIVED INFORMATION REGARDING AN ADJUSTABLE SHUNT. IT WAS REPORTED THAT ON (B)(6) 2025, UNDER GENERAL ANESTHESIA, THE PATIENT UNDERWENT LUMBAR CISTERN-ABDOMINAL SHUNT SURGERY. POSTOPERATIVELY, THE SHUNT VALVE PRESSURE WAS ADJUSTED MULTIPLE TIMES (ON (B)(6) 2025, TO SETTING 2.0, ON (B)(6) 2025, TO SETTING 1.5, AND ON (B)(6) 2025, TO SETTING 1.0). ON (B)(6) 2025, DUE TO RIGHT CHRONIC SUPPURATIVE OTITIS MEDIA WITH CHOLESTEATOMA, THE PATIENT UNDERWENT RIGHT OPEN MODIFIED RADICAL MASTOIDECTOMY, AND POSTOPERATIVE RECOVERY WAS GOOD. ON (B)(6) 2025, PHYSICAL EXAMINATION REVEALED SUBCUTANEOUS FLUID ACCUMULATION AT THE SHUNT RESERVOIR IN THE RIGHT HIP. AN URGENT SUPERFICIAL COLOR DOPPLER ULTRASOUND SHOWED AN ANECHOIC FLUID AREA SURROUNDING THE SHUNT TUBE. ON (B)(6) 2025, APPROXIMATELY 10 ML OF FLUID (LIGHT RED, ODORLESS) WAS ASPIRATED BY PUNCTURE, AND THE SHUNT VALVE PRESSURE WAS FURTHER ADJUSTED TO SETTING 1.0. ON (B)(6) 2025, PHYSICAL EXAMINATION SHOWED THAT THE SENSATION OF FLUID ACCUMULATION WAS REDUCED COMPARED TO BEFORE, WITH NO REDNESS OR TENDERNESS. TO EVALUATE SHUNT FUNCTION, AN URGENT UPRIGHT ABDOMINAL X-RAY WAS PERFORMED, WHICH INDICATED "DISCONTINUITY AT THE SHUNT VALV
Patient problems: Seroma
MAUDE report 23025512 ↗InjuryMay 14, 2025Fluid/Blood Leak; Fluid/Blood Leak
MEDTRONIC RECEIVED INFORMATION REGARDING AN ADJUSTABLE VALVE. IT WAS REPORTED THAT DURING HOSPITALIZATION FOLLOWING THE LUMBOPERITONEAL SURGERY, A SUSPECTED LEAK WAS DETECTED IN THE SHUNT. UPON SURGICAL EXPLORATION, THE VALVE WAS FOUND TO BE LEAKING. THE VALVE WAS REPLACED DURING THE PROCEDURE. THE PATIENT'S STATUS AT THE TIME OF THE REPORT WAS ALIVE-NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22017625 ↗MalfunctionMar 26, 2025Break; Fracture; Break; Fracture
MEDTRONIC RECEIVED INFORMATION REGARDING AN ADJUSTABLE SHUNT. IT WAS REPORTED THAT ON (B)(6) 2025, IN THE OPERATING ROOM, THE DOCTOR PERFORMED A LUMBAR SACRAL PERITONEAL SHUNT. DURING THE OPERATION, THE CATHETER WAS FOUND TO BE DAMAGED. THE PROCEDURE WAS COMPLETED WITH BACK UP PRODUCTS. THE PATIENT'S STATUS AT THE TIME OF THE REPORT WAS ALIVE-NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21699179 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K123524. One submission often covers many models, so check the product and lot details in each record.
- Z-1116-2021 · Jan 11, 2021 · Open, ClassifiedMedtronic Cerebro Spinal Fluid Flow Control Valves and Shunts. STRATA II Valves and Shunts for the following CFNs: 27739 - SHUNT 27739 STRATA NSC SNAP SML 120CM, 27740 - SHU
Other Shunt, central nervous system and components devices
- NATUS EDS3 DRAINAGE SYSTEM NT821731CNatus Medical Incorporated · Shunt, Central Nervous System And Components1 recall208 reports
- Exacta™ 46700Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 recall2 deaths163 reports
- Strata® 42866Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 death160 reports
- proGAV 2.0® FX410TChristoph Miethke GmbH & Co. KG · Shunt, central nervous system and components119 reports
- PROGAV 2.0 FX643TAesculap AG · Shunt, central nervous system and components100 reports
- Becker® 46128Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 recall50 reports
- M.BLUE PLUS FX804TAesculap AG · Shunt, central nervous system and components82 reports
- proSA® FV701TChristoph Miethke GmbH & Co. KG · Shunt, central nervous system and components82 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page